HOME >> MEDICINE >> NEWS
Two centres for infectious diseases established

The Netherlands Organisation for Scientific Research (NWO) has awarded a so-called centre subsidy to two research centres which are currently being established. Each centre will receive a total of 1.35 million euros. These funds must be used by the centres over the next five years to carry out multidisciplinary research towards the prevention, management or treatment of infectious diseases in the Netherlands or in developing countries. The focus is on flu, AIDS, malaria and tuberculosis.

Flu vaccine
Under the leadership of Prof. J.C. (]an) Wilschut, Departments of Medical Microbiology and Molecular Virology, University of Groningen In this centre, named NIVAREC (Netherlands Influenza Vaccine Research Centre), researchers from the University of Groningen and the Erasmus MC Rotterdam will work together with researchers from Solvay Pharmaceuticals in Weesp. The centre wants to develop and produce new flu vaccines to ensure that the Netherlands is optimally prepared for a flu pandemic.

AIDS, malaria and tuberculosis
Under the leadership of Prof. J.W.M. (Jos) van der Meer, Department of General Internal Medicine, Nijmegen University Medical Centre This centre, named PRIOR (Poverty Relationship Infection Oriented Research), forms a unique cooperation for the control of poverty-related infectious diseases in the third world. Researchers from Nijmegen University Medical Centre, Leiden University Medical Center, Universiteit Maastricht, Wageningen University and Research Centre and the National Institute of Public Health and the Environment (RIVM) will work together with colleagues in Tanzania and Indonesia. The aim is to develop a knowledge infrastructure in third world countries for poverty-related infectious diseases.

The subsidy for research centres is one of the initiatives from ZonMw (Netherlands Organisation for Health Research and Development) and NWO to stimulate research into infectious diseases. In 2002 TOPIZ,
'"/>

Contact: Sonja Jacobs
news@nwo.nl
Netherlands Organization for Scientific Research
5-Feb-2004


Page: 1 2

Related medicine news :

1. New Canadian study demonstrates clear survival benefit of treatment in trials and at large centres
2. Medically supervised injecting centres should be piloted in the UK
3. Walk-in centres perform well compared with general practice
4. High brain centres teach lower brain to adapt to injury
5. Physicians call for increased funding for federal infectious disease programs
6. Mailman School of Public Health researchers develop infectious disease diagnostic tool
7. Childrens Hospital Oakland opens new $5.6 million infectious disease lab
8. NIAID launches program to improve medical tools against emerging infectious diseases
9. Study suggests better use of web could improve infectious disease reporting
10. International public health expert Jeffrey Koplan addresses emerging infectious diseases conference
11. The lancet infectious diseases (TLID) October press release

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Two centres for infectious diseases established

(Date:4/21/2015)... The report “Dermatitis – ... on the therapeutic development for Dermatitis. ... new targets and MOAs to produce first-in-class ... is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html . ... involved in the therapeutic development for Dermatitis ...
(Date:4/21/2015)... Edward Avalos, USDA Under Secretary for Marketing and ... the California Department of Food and Agriculture, have been ... Conference: The Future of Local Food, conference organizers announced ... known experts intensifies an already strong line-up of sustainable ... to speak at the June 11-13 event. ...
(Date:4/21/2015)... Wojo Nutrition announces Abe’s ... its healthiest, will carry Wojo Nutrition's lines of single ... Nutrition, they’ve launched a revolution in the vitamin industry ... meet their multifaceted goals. Their line of single serving ... has been specially formulated to be as unique as ...
(Date:4/21/2015)... has released a new blog post explaining the ... , Comprehensive auto insurance is a complex policy ... limit can also be high and the premiums are ... against fire damage, vandalism, theft and from many other ... and it can help drivers find the right type ...
(Date:4/21/2015)... Health Advocate™, Inc., the nation’s leading ... West Corporation, is hosting a complimentary webinar on April ... benefits of offering this service to employees. , As ... their healthcare, it is critical that they have access ... their health benefits. Health advocates can play a significant ...
Breaking Medicine News(10 mins):Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 3Health News:Wojo Nutrition Announces their Lines of Single Serving Liquid Vitamins will be Available for Purchase online at Abesmarket.com Beginning in May 2Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2Health News:Health Advocate Webinar Discusses Benefits of Health Advocacy 2
(Date:4/21/2015)... SPRING, Md. , April 21, 2015 /PRNewswire-USNewswire/ ... told the U.S. Food and Drug Administration that ... worked effectively for the last 25 years to ... to safe homeopathic medicines. AAHP, the industry,s trade ... and consumers of homeopathic medicines to engage in ...
(Date:4/21/2015)... 21, 2015 Delcath Systems, Inc. (NASDAQ: ... Trial Authorizations (CTAs) filed with the U.K.,s ... and Germany,s Federal Institute for ... the Company,s global Phase 2 program for the treatment ... or HCC), to include a cohort of patients with ...
(Date:4/21/2015)... , April 21, 2015   Mast ... biopharmaceutical company leveraging its molecular adhesion and sealant ... sickle cell disease, heart failure, and arterial disease, ... EPIC study of its lead product ... surpassed the halfway point. Consistent with prior guidance, ...
Breaking Medicine Technology:Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework 2Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 2Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 3Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 4Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 2Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 3Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 4Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 5
Cached News: